methylprednisolone and low molecular weight heparin
|
Therapy |
|
methylprednisolone and unfractionated heparin
|
Therapy |
|
non-invasive mechanical ventilation
|
Therapy |
|
not receive any treatment
|
Therapy |
|
Prevention of or induction of TxA2
|
Therapy |
|
sarilumab + methylprednisolone plus SOC for COVID-19
|
Therapy |
|
target RAS using specific candidate chemotherapeutic drugs
|
Therapy |
|
transfusion of 2 or more units of packed red blood cells in a day
|
Therapy |
|